Disease-Causing Mutations and Rearrangements in Long Non-coding RNA Gene Loci

被引:52
|
作者
Aznaourova, Marina [1 ]
Schmerer, Nils [1 ]
Schmeck, Bernd [1 ,2 ,3 ]
Schulte, Leon N. [1 ,2 ]
机构
[1] Philipps Univ Marburg, Inst Lung Res, Marburg, Germany
[2] Philipps Univ Marburg, German Ctr Lung Res DZL, Syst Biol Platform, Marburg, Germany
[3] Philipps Univ Marburg, Ctr Synthet Microbiol SYNMIKRO, Marburg, Germany
关键词
long non-coding RNA; genome-wide association study; variation (genetic); disease; single nucleotide polymorphism; mutation; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; GERM-LINE DELETION; BREAST-CANCER; UP-REGULATION; EMERGING ROLE; CELL-PROLIFERATION; CANDIDATE GENE; GROWTH ARREST; EXPRESSION;
D O I
10.3389/fgene.2020.527484
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The classic understanding of molecular disease-mechanisms is largely based on protein-centric models. During the past decade however, genetic studies have identified numerous disease-loci in the human genome that do not encode proteins. Such non-coding DNA variants increasingly gain attention in diagnostics and personalized medicine. Of particular interest are long non-coding RNA (lncRNA) genes, which generate transcripts longer than 200 nucleotides that are not translated into proteins. While most of the estimated similar to 20,000 lncRNAs currently remain of unknown function, a growing number of genetic studies link lncRNA gene aberrations with the development of human diseases, including diabetes, AIDS, inflammatory bowel disease, or cancer. This suggests that the protein-centric view of human diseases does not capture the full complexity of molecular patho-mechanisms, with important consequences for molecular diagnostics and therapy. This review illustrates well-documented lncRNA gene aberrations causatively linked to human diseases and discusses potential lessons for molecular disease models, diagnostics, and therapy.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] Role of long non-coding RNA in inflammatory bowel disease
    Hu, Yufei
    Lu, Yifan
    Fang, Yi
    Zhang, Qizhe
    Zheng, Zhuoqun
    Zheng, Xiaojuan
    Ye, Xiaohua
    Chen, Yanping
    Ding, Jin
    Yang, Jianfeng
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [22] Long Non-Coding RNA in Cancer
    Hauptman, Nina
    Glavac, Damjan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (03) : 4655 - 4669
  • [23] Long non-coding RNA: Functional agent for disease traits
    Jain, Sriyans
    Thakkar, Nirav
    Chhatai, Jagamohan
    Bhadra, Manika Pal
    Bhadra, Utpal
    RNA BIOLOGY, 2017, 14 (05) : 522 - 535
  • [24] The role of long non-coding RNA in Crohn's disease
    Chen, Guo
    Deng, Heng
    Li, Ming
    Fang, Xiaoli
    He, Chunrong
    Shu, Yingzi
    Wang, Feifei
    HELIYON, 2024, 10 (11)
  • [25] Long non-coding RNA and cancer
    Akiyama, Tetsu
    Nishida, Naohiro
    CANCER SCIENCE, 2018, 109 : 1101 - 1101
  • [26] Long Non-Coding RNA Epigenetics
    Kazimierczyk, Marek
    Wrzesinski, Jan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [27] Long non-coding RNA and cancer
    Diederichs, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S13 - S13
  • [28] Long non-coding RNA stability
    Hannah Stower
    Nature Reviews Genetics, 2012, 13 (5) : 298 - 298
  • [29] Disease-causing gene-flanking genomic rearrangements in HNPCC patients
    Monika Morak
    Trisari Massdorf
    Melanie Locher
    Elke Holinski-Feder
    Hereditary Cancer in Clinical Practice, 9 (Suppl 1)
  • [30] The BRAF activated non-coding RNA: A pivotal long non-coding RNA in human malignancies
    Liu, Xiu-Fen
    Hao, Ji-Long
    Xie, Tian
    Pant, Om Prakash
    Lu, Cheng-Bo
    Lu, Cheng-Wei
    Zhou, Dan-Dan
    CELL PROLIFERATION, 2018, 51 (04)